Musk’s DOGE Cuts Target FDA Lab Guarding US Drug Supply
This article is for subscribers only.
A key lab that oversees US pharmaceutical safety is in limbo following moves by the Department of Government Efficiency, raising questions about the fate of the lab and the new administration’s approach to expensive but crucial research that aims to keep America’s product supply safe.
The lab’s workers said they were notified Wednesday that the facility wouldn’t be closed, but the lab remains on the government’s target list. Higher-ups with knowledge of the lab’s work have advocated to keep it open, people familiar with the situation said.